Assessing global cardiovascular molecular calcification with 18F-fluoride PET/CT: Will this become a clinical reality and a challenge to CT calcification scoring?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 4, 2012, Pages 660-664

  Basu, Sandip ^a   Høilund Carlsen, Poul F ^b   Alavi, Abass ^c  

^a TATA MEMORIAL HOSPITAL   (India)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; SODIUM FLUORIDE F 18; TRACER;

APOPTOSIS; ARTERY CALCIFICATION; ATHEROMATOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DISEASE COURSE; DRUG UPTAKE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MACROPHAGE; NON INVASIVE PROCEDURE; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOSIS;

EID: 84862524123     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-2048-x     Document Type: Review

References (23)

1. Perrone-Filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A. Molecular imaging of atherosclerosis in translational medicine. Eur J Nucl Med Mol Imaging 2011;38 (5) : 969-75.
2. Glaudemans AW, Slart RH, Bozzao A, Bonanno E, Arca M, Dierckx RA, Signore A. Molecular imaging in atherosclerosis. Eur J Nucl Med Mol Imaging 2010;37(12) : 2381-97.
3. Chen W, Bural GG, Torigian DA, Rader DJ, Alavi A. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 2009;36(1) : 144-51.
4. Lucignani G. Imaging atherosclerosis in the vulnerable patient. Eur J Nucl Med Mol Imaging 2007;34(1) : 143-6.
5. Hartung D, Schäfers M, Fujimoto S, Levkau B, Narula N, Kopka K, Virmani R, Reutelingsperger C, Hofstra L, Kolodgie FD, Petrov A, Narula J. Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions. Eur J Nucl Med Mol Imaging 2007;34 Suppl 1: S1-8.
6. Derlin T, Richter U, Bannas P, Begemann P, Buchert R, Mester J, Klutmann S. Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 2010;51(6) : 862-5.
7. Derlin T, Wisotzki C, Richter U, Apostolova I, Bannas P,Weber C, Mester J, Klutmann S. In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: correlation with atherogenic risk factors. J Nucl Med 2011;52(3) : 362-8.
8. Li Y, Berenji GR, Shaba WF, Tafti B, Yevdayev E, Dadparvar S. Association of vascular fluoride uptake with vascular calcification and coronary artery disease. Nucl Med Commun 2012;33(1) : 14-20.
9. Beheshti M, Saboury B, Mehta NN, Torigian DA, Werner T, Mohler E,Wilensky R, Newberg AB, Basu S, LangstegerW, Alavi A. Detection and global quantification of cardiovascular molecular calcification by fluoro-18-fluoride positron emission tomography/ computed tomography-a novel concept. Hell J Nucl Med 2011;14(2) : 114-20.
10. Derlin T, Tóth Z, Papp L, Wisotzki C, Apostolova I, Habermann CR, Mester J, Klutmann S. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18Ffluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. J Nucl Med 2011;52(7) : 1020-7.
11. Ben-Haim S, Kupzov E, Tamir A, Israel O. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 2004;45(11) : 1816-21
12. Dunphy MP, Freiman A, Larson SM, Strauss HW. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 2005;46(8) : 1278-84.
13. Ben-Haim S, Kupzov E, Tamir A, Frenkel A, Israel O. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. J Nucl Cardiol 2006;13 (6) : 791-800.
14. Schinke T, McKee MD, Karsenty G. Extracellularmatrix calcification: where is the action? Nat Genet 1999;21(2) : 150-1.
15. Schinke T, Karsenty G. Vascular calcification-a passive process in need of inhibitors. Nephrol Dial Transplant 2000;15(9) : 1272-4.
16. Diederichsen AC, Sand NP, Nørgaard B, Lambrechtsen J, Jensen JM, Munkholm H, Aziz A, Gerke O, Egstrup K, Larsen ML, Petersen H, Høilund-Carlsen PF, Mickley H. Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study. Eur J Cardiovasc Prev Rehabil 2011 Apr 27. [Epub ahead of print].
17. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010;30(7) : 1282-92.
18. Ylä-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, KwakBR, MarxN, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW,Waltenberger J, Weber C, Tokgözoglu L. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Thromb Haemost 2011;106(1) : 1-19.
19. Falk E, Shah PK. The SHAPE guideline: ahead of its time or just in time? Curr Atheroscler Rep 2011;13(5) : 345-52.
20. Tahara N, Imaizumi T, Virmani R, Narula J. Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med 2009;50(3) : 331-4.
21. Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, Kolodny G, Laham R. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009;50(4) : 563-8.
22. Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med 2008;5 Suppl 2: S2-S10.
23. Saboury B., Ziai P., Alavi A. Detection and quantification of molecular calcification by PET/computed tomography: A new paradigm in assessing atherosclerosis. PET Clinics 2011;6(4) : 409-415.